Search for: "MAJOR PHARMACEUTICALS" Results 281 - 300 of 4,367
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
18 Nov 2008, 7:23 pm
The money results from 3 major settlements with a device manufacturer and two pharmaceutical companies: Merck, Cephalon and Kyphon. [read post]
31 Jul 2014, 7:20 am by Bob Kraft
The Washington Post reported that major pharmaceutical companies funded a “scientific panel that shaped the federal government’s policy for testing the safety and effectiveness of painkillers. [read post]
24 Oct 2008, 11:37 am
Swiss-drug major Novartis has filed a lawsuit in the US District Court for the District of New Jersey against Mylan Pharmaceuticals Inc. for infringement of Orange Book listed US Patent No. 5,354,772 (the ‘772 patent) for Lescol capsules, generically known as Fluvastatin Sodium. [read post]
14 Aug 2013, 1:07 am by Editors
A new report on in-house counsel compensation reveals some insights on General Counsel pay – here’s hoping for more data from General Counsel Metrics, LLC and MLA in the near future: General counsel working in the extractive/chemical/mining, food and beverages, pharmaceuticals and medical devices industries are the highest paid among their peers, according to a study by legal search firm Major Lindsey & Africa (MLA) and law department benchmarking company General… [read post]
17 Jun 2008, 1:07 pm
A new study developed by market intelligence firm Cutting Edge Information reveals that the majority of pharmaceutical companies are waiting until their patents on drugs are nearly run out before they start to work on patent litigation strategies.According to the study:• 66% do not begin counter-generics planning until at least two years after product launch. [read post]
23 Jun 2013, 8:27 am by Mark Summerfield
As regular readers of this blog would be well-aware, the majority of provisions in the Raising the Bar Act came into effect on 15 April 2013. [read post]
3 Jan 2013, 11:11 am by Geoff Cockrell
Warburg Pincus acquired JHP Pharmaceuticals from JHP Holdings LLC, an entity majority-owned by Morgan Stanley Principal Investments. [read post]
22 Sep 2009, 3:09 pm by fraudfighters
Biovail, a major player in the pharmaceutical industry, pled guilty last week to charges of paying illegal kickbacks to medical professionals who recommended or prescribed Biovail’s hypertension drug, Cardizem L.A. [read post]
3 Apr 2014, 1:53 pm by admin
The vast majority of these cases have been brought by patients claiming physical injury from drugs prescribed as a result of misleading drug marketing. [read post]
10 Jan 2012, 3:00 am
In 2010, Novartis International AG, a major manufacturer of generic prescription drugs, recorded sales of $46.806 billion. [read post]
25 May 2023, 4:15 am by Eli Mazour
After over 47 years of focusing on pharmaceutical patents, Tom has the unique vantage point of someone who saw the field explode after the passage of the Hatch-Waxman Act and the creation of the Federal Circuit. [read post]
23 Oct 2014, 9:36 pm by Patent Docs
Noonan -- The Generic Pharmaceutical Association (GPhA) issued a statement today regarding ongoing talks between major Pacific Rim countries (including the U.S.) related to the proposed Trans-Pacific Partnership Agreement. [read post]
13 Feb 2015, 6:02 pm by Patent Docs
ACI faculty will help attendees: • Master the basics of the application and approval processes for drugs, biologics, and devices; • Comprehend the structure of the FDA and the roles of the three major agency centers: CDER, CBER, and CDHR; • Develop a practical working knowledge of clinical trials for drugs and biologics and the clearance process for devices; • Learn how devices are classified, monitored, and regulated; • Appreciate the complexities of… [read post]
5 Sep 2015, 8:20 pm by Patent Docs
ACI faculty will help attendees: • Master the basics of the application and approval processes for drugs, biologics, and devices; • Comprehend the structure of the FDA and the roles of the three major agency centers: CDER, CBER, and CDHR; • Develop a practical working knowledge of clinical trials for drugs and biologics and the clearance process for devices; • Learn how devices are classified, monitored, and regulated; • Appreciate the complexities of… [read post]
11 Jul 2014, 9:33 pm by Patent Docs
ACI faculty will help attendees: • Master the basics of the application and approval processes for drugs, biologics, and devices; • Comprehend the structure of the FDA and the roles of the three major agency centers: CDER, CBER, and CDHR; • Develop a practical working knowledge of clinical trials for drugs and biologics and the clearance process for devices; • Learn how devices are classified, monitored, and regulated; • Appreciate the complexities of… [read post]
12 Jul 2013, 8:51 pm by Patent Docs
ACI faculty will help attendees: • Master the basics of the application and approval processes for drugs, biologics, and devices • Comprehend the structure of the FDA and the roles of the three major agency centers: CDER, CBER, and CDHR • Develop a practical working knowledge of clinical trials for drugs and biologics and the clearance process for devices • Learn how devices are classified, monitored, and regulated • Appreciate the complexities of… [read post]
17 Jan 2014, 8:24 pm by Patent Docs
ACI faculty will help attendees: • Master the basics of the application and approval processes for drugs, biologics, and devices; • Comprehend the structure of the FDA and the roles of the three major agency centers: CDER, CBER, and CDHR; • Develop a practical working knowledge of clinical trials for drugs and biologics and the clearance process for devices; • Learn how devices are classified, monitored, and regulated; • Appreciate the complexities of… [read post]
18 Jan 2013, 9:59 pm by Patent Docs
ACI faculty will help attendees: • Master the basics of the application and approval processes for drugs, biologics, and devices; • Comprehend the structure of the FDA and the roles of the three major agency centers: CDER, CBER, and CDHR; • Develop a practical working knowledge of clinical trials for drugs and biologics and the clearance process for devices; • Learn how devices are classified, monitored, and regulated; • Appreciate the complexities of… [read post]
26 Sep 2021, 9:55 am by Patent Docs
Xiaofan Chen of AWA Asia and Gene Quinn of IPWatchdog, Inc. will discuss China's new Patent Law -- the first major update to the law since 2008, which entered into force on June 1, 2021, and which brings substantial changes, including the creation of a patent linkage system, introduces an open license system, improves protection for industrial designs as well as several new provisions directed towards pharmaceuticals, and strengthens patent enforcement.... [read post]
24 Oct 2022, 10:49 am by Eileen McDermott
Two major trade organizations representing global vaccine manufacturers are officially backing a proposal submitted to the G20 and G7 countries in July that they claim offers practical solutions for future pandemics to avoid the inequities that have been highlighted by the COVID-19 pandemic. [read post]